SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001176256-20-000126
Filing Date
2020-04-08
Accepted
2020-04-08 09:41:47
Documents
10
Period of Report
2020-04-08

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER FOR THE MONTH OF APRIL 2020 bellushealth6kmpm.htm 6-K 5060
2 NOTICE OF THE MEETING exhibit99-1.htm EX-99.1 5295
3 MANAGEMENT INFORMATION CIRCULAR exhibit99-2.htm EX-99.2 311845
4 FORM OF PROXY exhibit99-3.htm EX-99.3 30813
5 CERTIFICATE OF ABRIDGEMENT exhibit99-4.htm EX-99.4 4568
6 cpulogo.jpg GRAPHIC 2986
7 exhibit99-2x1x1.jpg GRAPHIC 15976
8 exhibit99-2x13x1.jpg GRAPHIC 95751
9 exhibit99-3x1x1.jpg GRAPHIC 4011
10 exhibit99-3x1x3.jpg GRAPHIC 4547
  Complete submission text file 0001176256-20-000126.txt   529034
Mailing Address 275 ARMAND-FRAPPIER BLVD. LAVAL A8 H7V 4A7
Business Address 275 ARMAND-FRAPPIER BLVD. LAVAL A8 H7V 4A7 450-680-4500
BELLUS Health Inc. (Filer) CIK: 0001259942 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39034 | Film No.: 20781306
SIC: 2834 Pharmaceutical Preparations